Sustained Viral Response in Genotype 4 Chronic Hepatitis C Virus–infected Children and Adolescents Treated With Sofosbuvir/Ledipasvir-Reference-Cited by-同舟云学术

Sustained Viral Response in Genotype 4 Chronic Hepatitis C Virus–infected Children and Adolescents Treated With Sofosbuvir/Ledipasvir

Published:2018-11 Issue:5 Volume:67 Page:626-630
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

El-Karaksy Hanaa,Mogahed Engy Adel,Abdullatif Hala,Ghobrial Carolyne,El-Raziky Mona S.,El-Koofy Nehal,El-Shabrawi Mortada,Ghita Haytham,Baroudy Sherif,Okasha Sawsan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

2. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin;Wirth;J Hepatol,2010

3. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C;Schwarz;Gastroenterology,2011

4. Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis;Druyts;Clin Infect Dis,2013

5. Safety and efficacy of combined treatment with pegylated interferon alpha-2b and ribavirin for HCV genotype 4 in children;El-Karaksy;J Interferon Cytokine Res,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

2. Should they wait? Two children under 3 years old infected by HCV 1b successfully treated by ledipasvir/sofosbuvir: A report of two cases;Liver Research;2023-12

3. The impact of sofosbuvir/ledipasvir on chronic hepatitis C-infected paediatric patients: a Middle East single-centre experience;Gastroenterology Review;2023

4. Treatment of hepatitis C in children and adolescents: how far have we reached?;World Journal of Pediatrics;2022-09-21

5. Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities;Pediatric Drugs;2022-07-15